Quick Answer
Wave Life Sciences Ltd. reported Cash And Cash Equivalents At Carrying Value of $602.07 million for the year ending 2025.
- Wave Life Sciences Ltd. showed an increase of +99.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Wave Life Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), Wave Life Sciences Ltd.'s Cash And Cash Equivalents At Carrying Value has grown by 158,757.0%.
- Historical annual values: Fiscal year 2025: $602.07 million | Fiscal year 2024: $302.08 million | Fiscal year 2023: $200.35 million | Fiscal year 2022: $88.50 million | Fiscal year 2021: $150.56 million | Fiscal year 2020: $184.50 million | Fiscal year 2019: $147.16 million | Fiscal year 2018: $174.82 million | Fiscal year 2017: $142.50 million | Fiscal year 2016: $150.29 million | Fiscal year 2015: $161.22 million | Fiscal year 2014: $1.05 million | Fiscal year 2013: $439.0 thousand | Fiscal year 2012: $379.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: